- REAGENT SERVICES Hot!
-
PRODUCTS
-
Most Popular Reagents
-
Instruments
-
Antibodies
-
ELISA Kits
-
Protein Electrophoresis and Blotting
-
Protein and Antibody Purification
-
Recombinant Proteins
-
Molecular Biology
-
Stable Cell Lines
-
Cell Isolation and Activation
-
IVD Raw Materials
-
Therapy Applications
-
Resources
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Anti-Camelid VHH]()
MonoRab™ Anti-VHH Antibodies
-
![ELISA Kits]()
ELISA Kits
-
![Precast Gels]()
SurePAGE™ Precast Gels
-
![Quatro ProAb Automated Protein and Antibody Purification System]()
AmMag™ Quatro ProAb Automated Protein and Antibody Purification System
-
![Target Proteins]()
Target Proteins
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Stable Cell Lines]()
Stable Cell Lines
-
![Cell Isolation and Activation]()
Cell Isolation and Activation
-
![Quick
Order]()
Quick Order
-
![Quick
Order]()
Quick Order
- APPLICATIONS
- RESOURCES
- ABOUT US
Revolutionize Antibody Purification with AmMag™ Quatro ProAb 1300 at Axio Biopharma
At Axio BioPharma, innovation is guided by the mission to transform antibody discovery and development through AI-powered technology. To accelerate this vision, Founder and CEO Justin Byers adopted GenScript’s AmMag™ Quatro ProAb 1300. He explains how the platform has streamlined Axio’s antibody purification workflow and advanced the company’s approach to biomanufacturing.
Axio Biopharma CEO Justin Byer and team members with AmMag™ Quatro ProAb 1300 in their laboratory
GenScript: "What does your team work on, and how did you find AmMag™ Quatro ProAb 1300?"
Justin: "At Axio BioPharma, we focus on AI-driven antibody development, which requires a steady flow of high-quality data to train our models. While searching for a high-throughput, midi-scale purification platform, we discovered the AmMag™ Quatro ProAb 1300. Its easy-to-use magnetic method and flexible scalability turned out to be exactly what we needed."
GenScript: "What factors influenced your decision to choose AmMag™ Quatro ProAb 1300? Did you consider other options?"
Justin: "Automation and flexibility were our top priorities. We explored other systems at this scale, but most required extensive manual handling. With the ProAb 1300, we simply load the samples and run. The software is intuitive and allows us to fine-tune protocols for different antibody types with ease."
GenScript: "How has your workflow changed since adopting AmMag™ Quatro ProAb 1300?"
Justin: "The impact has been remarkable, we’ve reduced hands-on time and labor by 80%, and increased throughput from one run per day to three. This efficiency boost has been transformative for our team’s productivity."
GenScript: "How has your experience been with the GenScript team?"
Justin: "Working with the GenScript team has been an excellent experience. They are always responsive, supportive, and proactive in addressing our needs."
GenScript: "What would you tell a scientist considering AmMag™ Quatro ProAb 1300?"
Justin: "I’d say, definitely give it a try! The combination of full automation and scalable flexibility makes it a game-changer. We couldn’t be happier with our choice."
-
